Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment-Reference-Cited by-同舟云学术

Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment

Published:2010-03 Issue:1 Volume:209 Page:178-183
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Stojakovic Tatjana,Claudel Thierry,Putz-Bankuti Csilla,Fauler Günter,Scharnagl Hubert,Wagner Martin,Sourij Harald,Stauber Rudolf E.,Winkler Karl,März Winfried,Wascher Thomas C.,Trauner Michael

Funder

SFB LIPOTOX

the Austrian Science Foundation (FWF)

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference34 articles.

1. Clinical features and management of primary biliary cirrhosis;Crosignani;World J Gastroenterol,2008

2. Primary biliary cirrhosis;Kaplan;N Engl J Med,2005

3. Cholestatic syndromes;Trauner;Curr Opin Gastroenterol,2003

4. Primary biliary cirrhosis, hyperlipidemia, and atherosclerotic risk: a systematic review;Sorokin;Atherosclerosis,2007

5. Hypercholesterolaemia is not associated with early atherosclerotic lesions in primary biliary cirrhosis;Allocca;Gut,2006

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Statins in Chronic Liver Disease: Review of the Literature and Future Role;Seminars in Liver Disease;2024-05

2. Impact of statins in the liver: A bane or a boon?;Canadian Liver Journal;2024-03-13

3. A systematic review and meta-analysis of the effect of statin treatment on sVCAM-1 and sICAM-1;Expert Review of Clinical Pharmacology;2022-05-04

4. Individualized treatment options for patients with non-cirrhotic and cirrhotic liver disease;World Journal of Gastroenterology;2021-05-21

5. Lipolytic Postbiotic from Lactobacillus paracasei Manages Metabolic Syndrome in Albino Wistar Rats;Molecules;2021-01-18